Virtu KCG Holdings’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Virtu KCG Holdings’s Portfolio EPRS Stock Details EPRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-131,050	Closed	-$59K	–	3882
2016 Q2	$59K	Buy	131,050 +118,497	+944%	+$190K	﹤0.01%	2646
2016 Q1	$34K	Sell	12,553 -20,288	-62%	-$57K	﹤0.01%	2529
2015 Q4	$101K	Buy	32,841 +20,562	+167%	+$92.7K	﹤0.01%	2990
2015 Q3	$54K	Buy	+12,279	New	+$72.1K	﹤0.01%	2984
2015 Q2	–	Sell	-12,206	Closed	-$109K	–	4207
2015 Q1	$109K	Buy	+12,206	New	+$98K	﹤0.01%	2635
2014 Q4	–	Sell	-21,785	Closed	-$154K	–	4689
2014 Q3	$154K	Buy	+21,785	New	+$188K	﹤0.01%	3065

Other funds holding EPRS

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Virtu KCG Holdings's EPRS Position: Q3 2016 in Review

Virtu KCG Holdings sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q3 2016, closing a stake of 131,050 shares — an estimated $59K sold.

Virtu KCG Holdings first reported a position in EPRS in Q3 2014 and held it in 6 quarters. The position peaked at $154K in Q3 2014. 3 funds tracked by Wall St. Rank hold EPRS as of Q3 2016.

Virtu KCG Holdings reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q3 2016 after selling out during the quarter.
Virtu KCG Holdings sold 131,050 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q3 2016, an estimated $59K.
Virtu KCG Holdings first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q3 2014 and held it in 6 quarters.
Virtu KCG Holdings's EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $154K in Q3 2014.
3 funds tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q3 2016.

Based on Virtu KCG Holdings's 13F filing for Q3 2016, filed 10 Nov 2016.